Editas Medicine, Inc. announced the appointment of Michelle Robertson as the Company's Chief Financial Officer, principal accounting officer, principal financial officer, Treasurer and Assistant Secretary of the company, effective January 9, 2020. Ms. Robertson succeeded Eric Ek, whose service as the Company's interim Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer ended upon Ms. Robertson's appointment, and the appointment of Harry Gill in the newly created role of Senior Vice President, Operations, both effective January 9, 2020. Michelle Robertson brings to Editas Medicine more than 25 years of biotech finance and commercial operations management experience.  Ms. Robertson joins Editas Medicine from Momenta Pharmaceuticals, Inc., where she held roles of increasing responsibility, most recently serving as Chief Financial Officer.

Prior to joining Momenta, Ms. Robertson was Vice President, Oncology Finance for Baxalta, Inc. (which was acquired by Shire PLC in 2016) following its spin-out from Baxter International in July 2015. Before that, Ms. Robertson served as head of Financial Planning and Analysis and Operations at Ironwood Pharmaceuticals, and, prior to that, she held various leadership positions in the Oncology and Biosurgery divisions with Finance and Commercial Operations, focusin on financial analysis for business development, acquisition integrations, and divestitures at Genzyme Corporation. Ms. Robertson earned a BS in Finance from Bentley University Harry Gill brings more than 30 years of life sciences experience to Editas Medicine.

Throughout his career, Mr. Gill has held leadership roles in quality, plant operations, technical services, and operational excellence, including serving as Senior Vice President of Quality and Continuous Improvement at Patheon Pharmaceuticals (now ThermoFisher Scientific). Earlier in his career, he held various positions at Wyeth (now Pfizer Pharmaceuticals) and Baxter Healthcare Corporation. Mr. Gill received a BS degree in biology from Milligan College and a MS in microbiology from East Tennessee State University.